Arctigenin-Enriched Burdock Seed Oil (ABSO): A New Skin Brightening Botanical Extract

The Arctium lappa L. plant, commonly known as burdock, has been used therapeutically for hundreds of years. Arctigenin (ATG) is an active ingredient in burdock, albeit at low quantities or mostly in the form of acrtiin (arctigenin-4-glucoside). ATG has been touted for its anti-inflammatory properties in many cell types and disease states; however, its role in skin and melanin production has not been extensively studied. Our aims for this study were to develop a burdock seed extract enriched for ATG that is amenable to quasi-drug development, determine in vitro brightening activity, and evaluate safety and skin brightening efficacy clinically in human subjects. Arctiin and ATG content were measured by high-performance liquid chromatography (HPLC). In vitro studies utilized EpiDermTM tissues for skin irritation test, and MelanoDermTM tissues for melanin reduction capacity. A 45 subject clinical study was performed in adult subjects ranging in age from 30 to 60 years old (mean = 41.9 ± 6.7) to test the safety and skin brightening potential of 1% ABSO lotion. We demonstrate by HPLC that ABSO is a natural extract that contains ~5-times more arctigenin than BSO. Furthermore, ABSO inhibits melanin production better than BSO and retains the same melanin-reducing capacity as synthetic ATG in vitro in MelanoDerm™ 3D skin cultures. ABSO also adheres to quasi-drug criteria according to the Japanese Standards of Quasi-Drug Ingredients as determined by infrared absorption spectrum method, unsaponifiable matter, heavy metal and arsenic content, and acid, saponification, and iodine value methods. Clinical assessment of 1% ABSO lotion shows it is well-tolerated in human skin and demonstrates improved brightness and skin tone evenness. ABSO is a natural arctigenin-enriched burdock seed extract that reduces melanin content in vitro and clinically improves skin brightness.

[1]  N. Vashi,et al.  Skin-Lightening Products: Consumer Preferences and Costs , 2021, Cureus.

[2]  I. Almeida,et al.  Trends in the Use of Botanicals in Anti-Aging Cosmetics , 2021, Molecules.

[3]  Young Eon Kim,et al.  Enhancement of the apoptotic effects of Arctii Fructus extracts on cancer cells by the enzymatic bioconversion of lignans , 2020, Food science & nutrition.

[4]  Andy Wai Kan Yeung,et al.  Arctium Species Secondary Metabolites Chemodiversity and Bioactivities , 2019, Front. Plant Sci..

[5]  S. García-Lara,et al.  Current Methods for the Discovery of New Active Ingredients from Natural Products for Cosmeceutical Applications , 2019, Planta Medica.

[6]  Z. Zuo,et al.  Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L , 2018, Acta Pharmacologica Sinica.

[7]  Enbo Cai,et al.  Novel Method of Preparation and Activity Research on Arctigenin from Fructus Arctii , 2018, Pharmacognosy magazine.

[8]  E. Secemsky,et al.  The impact of skin hyperpigmentation and hyperchromia on quality of life: A cross‐sectional study , 2017, Journal of the American Academy of Dermatology.

[9]  Jai-Sing Yang,et al.  Inhibitory effect of burdock leaves on elastase and tyrosinase activity. , 2017, Experimental and therapeutic medicine.

[10]  G. Leonardi,et al.  An overview about oxidation in clinical practice of skin aging* , 2017, Anais brasileiros de dermatologia.

[11]  Kunming Qin,et al.  Chemical analysis of raw and processed Fructus arctii by high-performance liquid chromatography/diode array detection-electrospray ionization-mass spectrometry , 2014, Pharmacognosy Magazine.

[12]  Mei Wang,et al.  Isolation and purification of arctigenin from Fructus Arctii by enzymatic hydrolysis combined with high-speed counter-current chromatography. , 2014, Journal of separation science.

[13]  Ji-Eun Kim,et al.  Inhibitory Effect of Arctigenin from Fructus Arctii Extract on Melanin Synthesis via Repression of Tyrosinase Expression , 2013, Evidence-based complementary and alternative medicine : eCAM.

[14]  M. Olsson,et al.  The melanogenesis and mechanisms of skin‐lightening agents – existing and new approaches , 2011, International journal of cosmetic science.

[15]  Y. Kwan,et al.  A review of the pharmacological effects of Arctium lappa (burdock) , 2011, Inflammopharmacology.

[16]  M. Ichihashi,et al.  Quasi-Drugs Developed in Japan for the Prevention or Treatment of Hyperpigmentary Disorders , 2010, International journal of molecular sciences.

[17]  M. Gallo,et al.  Metabolic profile of the bioactive compounds of burdock (Arctium lappa) seeds, roots and leaves. , 2010, Journal of pharmaceutical and biomedical analysis.

[18]  H. Kandárová,et al.  An in vitro skin irritation test (SIT) using the EpiDerm reconstructed human epidermal (RHE) model. , 2009, Journal of visualized experiments : JoVE.

[19]  Wen‐yuan Zhu,et al.  The use of botanical extracts as topical skin-lightening agents for the improvement of skin pigmentation disorders. , 2008, The journal of investigative dermatology. Symposium proceedings.

[20]  R. Halder,et al.  Ethnic skin disorders overview. , 2003, Journal of the American Academy of Dermatology.

[21]  G. Majmudar,et al.  An in vitro method for screening skin-whitening products , 1998 .